Markus Raderer
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Drug Transport and Resistance Mechanisms
Papers in
-
- Lymphoma Diagnosis and Treatment 184
- Oncology 62
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 8
- Co-authors
- Andreas Chott (65 shared papers)Berthold Streubel (37 shared papers)Michael Hejna (42 shared papers)Barbara Kiesewetter (99 shared papers)Werner Scheithauer (47 shared papers)Stefan Wöhrer (32 shared papers)Christoph Carl Zielinski (25 shared papers)Gabriela Verena Kornek (38 shared papers)
In The Last Decade
Markus Raderer
341 papers receiving 14k citations
Markus Raderer's Hit Papers
Peers
Comparison fields: 5 of 119
- Pathology and Forensic Medicine 6.1k
- Oncology 2.1k
- Epidemiology 2.2k
- Radiology, Nuclear Medicine and Imaging 778
- Hematology 445
Countries citing papers authored by Markus Raderer
This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).
Fields of papers citing papers by Markus Raderer
This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Raderer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 358 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors Hit paper breakdown → | 2014 | 1485 |
| 2 | 2003 | 380 | |
| 3 | 2004 | 311 | |
| 4 | 2005 | 292 | |
| 5 | 2011 | 275 | |
| 6 | Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2020 | 230 |
| 7 | 2005 | 225 | |
| 8 | 1999 | 212 | |
| 9 | 2015 | 207 | |
| 10 | 1993 | 205 | |
| 11 | 1996 | 198 | |
| 12 | 2015 | 192 | |
| 13 | 2016 | 190 | |
| 14 | 2012 | 178 | |
| 15 | 2011 | 169 | |
| 16 | 2013 | 169 | |
| 17 | 2002 | 158 | |
| 18 | 2001 | 155 | |
| 19 | 2004 | 155 | |
| 20 | 2017 | 155 |
About Markus Raderer
Markus Raderer is a scholar working on Pathology and Forensic Medicine, Oncology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 358 papers that have together received 14.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (184 papers), Neuroendocrine Tumor Research Advances (39 papers), Colorectal Cancer Treatments and Studies (14 papers), Helicobacter pylori-related gastroenterology studies (11 papers), Gastric Cancer Management and Outcomes (11 papers), Medical Imaging Techniques and Applications (11 papers), Cancer Treatment and Pharmacology (8 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.1k citations), Oncology (2.1k citations), Epidemiology (2.2k citations), Radiology, Nuclear Medicine and Imaging (778 citations) and Hematology (445 citations). Markus Raderer has collaborated with scholars based in Austria, Italy and Germany. Frequent co-authors include Andreas Chott, Berthold Streubel, Michael Hejna, Barbara Kiesewetter, Werner Scheithauer, Stefan Wöhrer, Christoph Carl Zielinski, Gabriela Verena Kornek, Ulrich Jaeger and Leonhard Müllauer. Their work appears in journals such as Annals of Oncology, Blood, Journal of Clinical Oncology, Hematological Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.